Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01489839 · ClinicalTrials.gov registry record
Biomarkers of Periodontal Disease Progression
A clinical trial, sponsored by The Forsyth Institute.
- Completed
- Registry status
- 157
- Enrollment target
NCT01489839: Completed study, sponsored by The Forsyth Institute.
NCT01489839 is a clinical trial that has completed, run by The Forsyth Institute. The registered enrollment target is 157 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01489839 has completed, sponsored by The Forsyth Institute.
- COMPLETED
- Registry status
- 157 participants
- Enrollment target
Study Summary
The primary purpose of the study will be to look for biological biomarkers to determine which people with gum disease will have a worsening of the disease. A second objective of this study will be to look at the effects of periodontal treatment on the levels of the biomarkers that are identified.
Primary Outcome
The primary study outcome will be progression of periodontal disease as determined by CAL. Initial disease progression at a site will be defined as loss of ≥2 mm in CAL at any assessment or follow-up visit compared with baseline. Subsequent disease progression will be similarly defined except that the loss in CAL will be compared with the last visit at which disease progression was detected.
Interventions
- OTHER Periodontal therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-05 |
What the finished NCT01489839 record still lists
NCT01489839 is an observational study that tracks outcomes without assigning an intervention. The registered 157 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Periodontal therapy is the first listed.
NCT01489839 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01489839 about?
NCT01489839 is a clinical study titled "Biomarkers of Periodontal Disease Progression". The primary purpose of the study will be to look for biological biomarkers to determine which people with gum disease will have a worsening of the disease. A second objective of this study will be to look at the effects of periodontal treatment on the levels of the biomarkers that are identified.
What is the current status of trial NCT01489839?
This trial is currently completed. The enrollment target is 157 participants. The study started on 2012-01. Estimated completion is 2017-05.
What interventions are being tested in trial NCT01489839?
The interventions under investigation include: Periodontal therapy (OTHER).
Who is sponsoring clinical trial NCT01489839?
This trial is sponsored by The Forsyth Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05052541 · 157 participants · Phase 3
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
- NCT05076942 · 157 participants · Phase 2
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
- NCT06396598 · 157 participants · NA
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
- NCT06655246 · 157 participants · Phase 1
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia